Stock search

Ticker or company name

Compare stocks

Market: US

  • BSXBoston Scientific
  • CAHCardinal Health
  • CORCencora

Add stock

Ticker or company

Summary

BSX
Boston Scientific
$43,69Down −1,47%
Year: Down −58%
83/100Best scoreRatio would consider buying
Open stock page
CAH
Cardinal Health
$283,85Up +0,98%
Year: Up +36%

Not enough data for a score

Open stock page
COR
Cencora
$356,94Down −0,58%
Year: Down −4%
83/100Best scoreRatio would consider buying
Open stock page

Verdict

BSX has the best score (83). CAH grows revenue the fastest. BSX is the cheapest by forward P/E. BSX has the lowest debt load. BSX has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckBSX6 ✓ 3 — 0 ✕CAH1 ✓ 0 — 2 ✕COR6 ✓ 3 — 0 ✕
P/E vs its history18,435,719,7
P/E vs industry18,435,719,7
Forward P/E14,019,216,8
Revenue growth, YoY+8,9%n/a—+5,1%
EPS growth, YoY+26,2%n/a—+38,3%
Net margin16,6%n/a—0,8%
Net debt / EBITDA−0,1n/a—2,4
Free cash flow$3,33 bnn/a—$4,06 bn
Share count over a year−2,9%n/a—−0,7%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterBSXTTMCAHTTMCORTTMIndustry medianTTM
P/E TTM ↓Best: 18,4Worst: 35,719,725,1
Forward P/E ↓Best: 14,0Worst: 19,216,816,2
PEG ↓Best: 0,7Worst: 3,12,42,2
P/S TTM ↓Worst: 3,10,3Best: 0,22,2
EV/EBITDA ↓15,6Worst: 23,2Best: 15,117,3
P/FCF ↓Worst: 19,313,3Best: 10,919,5

Price, %

  • BSXn/a
  • CAHn/a
  • CORn/a

Returns

Best WorstNo mark — in between

PeriodBSXCAHCOR
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

BSXCAHCOR
Share of “buy”Worst: 65%Best: 86%70%
Beat the forecastBest: 4 of 4Best: 4 of 4Worst: 3 of 4
Average “surprise”+1,5%Best: +9,5%Worst: +0,1%
Insiders over 12 monthssales $6,76 msales $61,6 msales $13,1 m

Details are on each stock page.